Skip to main content
Journal cover image

Temozolomide-induced flare in high-grade gliomas: a new clinical entity.

Publication ,  Journal Article
Rosenthal, MA; Ashley, DL; Cher, L
Published in: Intern Med J
July 2002

A transient deterioration in neurological status following commencement of chemotherapy for high-grade gliomas has not been previously described. We report eight cases of transient deterioration following administration of temozolomide, a relatively new cytotoxic agent used in the treatment of high-grade gliomas. We believe this represents the novel clinical entity of temozolomide-induced tumour flare.

Duke Scholars

Published In

Intern Med J

DOI

ISSN

1444-0903

Publication Date

July 2002

Volume

32

Issue

7

Start / End Page

346 / 348

Location

Australia

Related Subject Headings

  • Temozolomide
  • Severity of Illness Index
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Middle Aged
  • Male
  • Karnofsky Performance Status
  • Humans
  • Glioma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rosenthal, M. A., Ashley, D. L., & Cher, L. (2002). Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J, 32(7), 346–348. https://doi.org/10.1046/j.1445-5994.2002.00242.x
Rosenthal, M. A., D. L. Ashley, and L. Cher. “Temozolomide-induced flare in high-grade gliomas: a new clinical entity.Intern Med J 32, no. 7 (July 2002): 346–48. https://doi.org/10.1046/j.1445-5994.2002.00242.x.
Rosenthal MA, Ashley DL, Cher L. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J. 2002 Jul;32(7):346–8.
Rosenthal, M. A., et al. “Temozolomide-induced flare in high-grade gliomas: a new clinical entity.Intern Med J, vol. 32, no. 7, July 2002, pp. 346–48. Pubmed, doi:10.1046/j.1445-5994.2002.00242.x.
Rosenthal MA, Ashley DL, Cher L. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J. 2002 Jul;32(7):346–348.
Journal cover image

Published In

Intern Med J

DOI

ISSN

1444-0903

Publication Date

July 2002

Volume

32

Issue

7

Start / End Page

346 / 348

Location

Australia

Related Subject Headings

  • Temozolomide
  • Severity of Illness Index
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Middle Aged
  • Male
  • Karnofsky Performance Status
  • Humans
  • Glioma